Breaking Protocol

Breaking Protocol
Podcast Description
The clinical trial industry is stuck in an innovation impasse, weighed down by outdated processes, layers of bureaucracy, and a systemic inability to prioritize those on the frontlines - patients, sites, and researchers. Tune in every week as Tilda Research CEO Ram Yalamanchili interviews clinical trial leaders at the cutting edge of innovation who are breaking past the current paradigm.
Podcast Insights
Content Themes
Focused on innovation in clinical trials, featuring discussions on topics like the application of AI in clinical research, operational efficiency, and overcoming bureaucratic challenges with episodes highlighting experts like Dr. David Chin Yee and Dr. George Magrath who share insights on improving clinical outcomes and the future of treatment methodologies.

The clinical trial industry is stuck in an innovation impasse, weighed down by outdated processes, layers of bureaucracy, and a systemic inability to prioritize those on the frontlines – patients, sites, and researchers. Tune in every week as Tilda Research CEO Ram Yalamanchili interviews clinical trial leaders at the cutting edge of innovation who are breaking past the current paradigm.
ICON Eyecare experiences 66% data quality improvement and 90% increase in efficiency.
Dr. James Fox of ICON Eyecare (Grand Junction, CO) discusses what it really takes to scale clinical research today. He walks through the burnout his team faced, the turning point that led to adopting AI teammates, and the measurable improvements in data quality, team capacity, and growth. He unpacks the staffing paradox in research, the trust that's at stake, and what it means for the future when AI and humans work side-by-side. His site, running 30 trials with a lean team, is a case study in what happens when AI meets the real-world pressure of clinical operations.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.